Skip to Main Content
Guiyang Hao, Ph.D.

Guiyang Hao, Ph.D.

Associate Professor

School
Medical School
Department
Radiology
Graduate Programs
Biomedical Engineering
  • Education
    Undergraduate
    Beijing Normaluniversity-China (2000), Chemistry
    Graduate School
    Beijing Normaluniversity-China (2005), Chemistry
  • Research Interest
    • Design and evaluate molecular imaging probes for cancer, neurological disorders, and cardiovascular/metabolic diseases via positron emission tomography (PET), single photon emission computed tomography (SPECT), and fluorescence imaging.
  • Publications

    Star Featured Publications

    ImmunoPET Imaging with 89Zr-labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma.
    Mulgaonkar A, Elias R, Woolford L, Guan B, Nham K, Kapur P, Christie A, Tcheuyap VT, Singla N, Bowman IA, Stevens C, Hao G, Brugarolas J, Sun X, Clin Cancer Res 2022 Sep
    Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists.
    Debnath S, Hao G, Guan B, Thapa P, Hao J, Hammers H, Sun X, Int J Mol Sci 2022 Jun 23 13
    Comparison of BMIPP-SPECT/CT to 18FDG-PET/CT for Imaging Brown or Browning Fat in a Preclinical Model.
    Frankl JA, An Y, Sherwood A, Hao G, Huang FY, Thapa P, Clegg DJ, Sun X, Scherer PE, Öz OK, Int J Mol Sci 2022 Apr 23 9
    PSMA-Targeting Imaging and Theranostic Agents-Current Status and Future Perspective.
    Debnath S, Zhou N, McLaughlin M, Rice S, Pillai AK, Hao G, Sun X, Int J Mol Sci 2022 Jan 23 3
    Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer.
    Guan B, Zhou N, Wu CY, Li S, Chen YA, Debnath S, Hofstad M, Ma S, Raj GV, He D, Hsieh JT, Huang Y, Hao G, Sun X, Int J Mol Sci 2021 Dec 22 23
    Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT.
    Hao G, Mastren T, Silvers W, Hassan G, Öz OK, Sun X, Sci Rep 2021 Feb 11 1 3622
    Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET.
    Khare P, Sun W, Ramakrishnan S, Hao G, Lo ST, Nham K, Sun X, Ober RJ, Ward ES, Swiercz R, MAbs 2021 Jan-Dec 13 1 1976705
    Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.
    Butler E, Schwettmann B, Geboers S, Hao G, Kim J, Nham K, Sun X, Laetsch TW, Xu L, Williams NS, Skapek SX, Pediatr Blood Cancer 2020 Dec 67 12 e28639
    Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting.
    Lim J, Guan B, Nham K, Hao G, Sun X, Simanek EE, Biomolecules 2019 Aug 9 9
    PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers.
    Huang G, Zhao T, Wang C, Nham K, Xiong Y, Gao X, Wang Y, Hao G, Ge WP, Sun X, Sumer BD, Gao J, Nat Biomed Eng 2019 Jun
  • Honors & Awards
    • Fall 2009 North and Central Texas Clinical and Translational Science Initiative (NCTCTSI) Pilot Grant Award
      (2009)
    • Young Researcher Award, the Third International Workshop on Biomedical Imaging
      Fukui, Japan (2004)
  • Professional Associations/Affiliations
    • Society of Radiopharmaceutical Sciences (2010)
    • The American Chemical Society (2010)
    • The Society of Nuclear Medicine (2009)